Literature DB >> 22326873

Coupled intracerebral microdialysis and electrophysiology for the assessment of dopamine neuron function in vivo.

Francesca Panin1, Adeline Cathala, Pier Vincenzo Piazza, Umberto Spampinato.   

Abstract

INTRODUCTION: The central dopaminergic system is involved in the pathophysiology of several neuropsychiatric disorders. Intracerebral microdialysis and electrophysiology provide two powerful techniques to investigate dopamine (DA) function and the mechanism of action of psychotropic drugs in vivo.
METHODS: Here, we developed a protocol allowing the combined measurement of neurochemical and electrical activities of the nigrostriatal and mesoaccumbens DA pathways, by coupling in vivo microdialysis and electrophysiology in the same isoflurane-anesthetized animal. DA neuron firing rate and burst firing were measured in the substantia nigra pars compacta (SNc) and the ventral tegmental area (VTA), whereas extracellular levels of DA and its main metabolite 3,4-dihydroxyphenylacetic acid (DOPAC) were monitored in the striatum and the nucleus accumbens (NAc). The validity of the protocol was assessed using various drugs known to modify DA neuron activity in vivo.
RESULTS: The peripheral administration of the DA-D2 agonist quinpirole decreased SNc DA neuron firing rate and burst firing, as well as DA and DOPAC outflow in the rat striatum. Opposite effects were observed after the peripheral administration of the DA-D2 antagonist haloperidol. In rats and mice, the peripheral administration of cocaine elicited a decrease in VTA DA neuron firing rate and burst firing, and an increase in accumbal DA outflow, paralleled by a reduction in DOPAC outflow. DISCUSSION: The obtained results, confirming previous electrophysiological and microdialysis studies, demonstrate that this protocol provides a suitable method for the study of DA neuron function and the mechanism of action of psychotropic drugs in the living brain of both rats and mice.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22326873     DOI: 10.1016/j.vascn.2012.01.003

Source DB:  PubMed          Journal:  J Pharmacol Toxicol Methods        ISSN: 1056-8719            Impact factor:   1.950


  7 in total

1.  Frequency-dependent effects of ethanol on dopamine release in the nucleus accumbens.

Authors:  Jordan T Yorgason; Mark J Ferris; Scott C Steffensen; Sara R Jones
Journal:  Alcohol Clin Exp Res       Date:  2013-10-11       Impact factor: 3.455

2.  Differential Control of Cocaine Self-Administration by GABAergic and Glutamatergic CB1 Cannabinoid Receptors.

Authors:  Elena Martín-García; Lucie Bourgoin; Adeline Cathala; Fernando Kasanetz; Miguel Mondesir; Ana Gutiérrez-Rodriguez; Leire Reguero; Jean-François Fiancette; Pedro Grandes; Umberto Spampinato; Rafael Maldonado; Pier Vincenzo Piazza; Giovanni Marsicano; Véronique Deroche-Gamonet
Journal:  Neuropsychopharmacology       Date:  2015-11-27       Impact factor: 7.853

Review 3.  Heterogeneity of dopamine neuron activity across traits and states.

Authors:  M Marinelli; J E McCutcheon
Journal:  Neuroscience       Date:  2014-07-30       Impact factor: 3.590

4.  Permeation of Dopamine Sulfate through the Blood-Brain Barrier.

Authors:  Tina Suominen; T Petteri Piepponen; Risto Kostiainen
Journal:  PLoS One       Date:  2015-07-24       Impact factor: 3.240

5.  Real-time dopamine measurement in awake monkeys.

Authors:  Erik W Schluter; Andrew R Mitz; Joseph F Cheer; Bruno B Averbeck
Journal:  PLoS One       Date:  2014-06-12       Impact factor: 3.240

6.  Involvement of dopamine D2 receptors in addictive-like behaviour for acetaldehyde.

Authors:  Anna Brancato; Fulvio Plescia; Rosa Anna Maria Marino; Giuseppe Maniaci; Michele Navarra; Carla Cannizzaro
Journal:  PLoS One       Date:  2014-06-13       Impact factor: 3.240

7.  Adolescent Exposure to WIN 55212-2 Render the Nigrostriatal Dopaminergic Pathway Activated During Adulthood.

Authors:  Enzo Javier Pérez-Valenzuela; María Estela Andrés Coke; Anthony A Grace; José Antonio Fuentealba Evans
Journal:  Int J Neuropsychopharmacol       Date:  2020-12-03       Impact factor: 5.176

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.